Cart summary

You have no items in your shopping cart.

Vunakizumab Biosimilar (Anti-CTLA-8 / IL-17a Reference Antibody)

Vunakizumab Biosimilar (Anti-CTLA-8 / IL-17a Reference Antibody)

Catalog Number: orb2703663

Select Product Size
SizePriceQuantity
100 mg$ 3,370.00
100 mg Enquire
DispatchUsually dispatched within 5-10 working days
Product Properties
Catalog Numberorb2703663
CategoryAntibodies
DescriptionVunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGκ monoclonal antibody that targets IL-17A and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis and inflammatory arthritis.
TargetVunakizumab Biosimilar (Anti-CTLA-8 / IL-17a Reference Antibody)
ClonalityMonoclonal
ConjugationUnconjugated
Antibody TypeBiosimilar Antibody
CAS Number1792181-33-9
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
NoteFor research use only
Expiration Date12 months from date of receipt.
Images
Reviews

Vunakizumab Biosimilar (Anti-CTLA-8 / IL-17a Reference Antibody) (orb2703663)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet